share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lagarde Michel

SEC announcement ·  May 4 04:23
Summary by Futu AI
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Michel Lagarde, a key figure at the company. The transaction, which took place on May 1, 2024, did not specify the relationship of Lagarde to the issuer. Details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares after the action were not disclosed in the announcement.
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Michel Lagarde, a key figure at the company. The transaction, which took place on May 1, 2024, did not specify the relationship of Lagarde to the issuer. Details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares after the action were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.